“…Because of the technical difficulty of obtaining a homogenous preparation of juxtaglomerular cells from the kidney, this concept has not yet been substantiated by direct measurements of intracellular [Ca2+]. It is based on studies in which the extracellular [Ca2+] bathing in vitro preparations was changed (Van Dongen & Peart, 1974;Fray, 1977;Park & Malvin, 1978;Baumbach & Sk0tt, 1981;Churchill, 1981;Park et al 1981;Ginesi et al 1983) and also on experiments with a number of pharmacological agents. These include Ca channel blocking drugs such as verapamil (Park et al 1981), D600 (Churchill, 1981) and diltiazem (Churchill, McDonald & Churchill, 1981), calmodulin inhibitors such as trifluoperazine (Churchill & Churchill, 1983;Fray, Lush, Share & Valentine, 1983) and W-7 (Kawamura & Inagami, 1983), TMB-8, an antagonist to the release of Ca2+ from intracellular sites (Fray & Lush, 1984;Baxter, Lazzaro, Duggin, Horvath & Tiller, 1985) and blockers L. M. GJNESI AND A. R. NOBLE of the Na-K-ATPase such as ouabain (Lyons & Churchill, 1975), vanadate (Churchill & Churchill, 1980b) and quinacrine .…”